Journal of Assisted Reproduction and Genetics

, Volume 9, Issue 4, pp 338–344 | Cite as

Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality

  • Hung-Ching Liu
  • Ying-Ming Lai
  • Owen Davis
  • Alan S. Berkeley
  • Margaret Graf
  • Jimmy Grifo
  • Jacques Cohen
  • Zev Rosenwaks
Clinical Assisted Reproduction

Abstract

The impact of gonadotropin releasing hormone agonist (GnRH-a) on the quality and quantity of oocytes harvested in in vitro fertilization—embryo transfer (IVF-ET) patients was studied by comparing the results for patients stimulated with gonadotropin alone and with gonadotropin plus GnRH-a. Adding GnRH-a significantly improved the viable pregnancies per transfer and reduced the spontaneous abortions, which seemed to improve oocyte quality. However, when oocyte quality was evaluated by the fertilization rate and the implantation and delivery rates per embryos transferred, there were no significant difference in the results, indicating that GnRH-a did not improve the oocyte quality. On the other hand, GnRH-a significantly increased the average number of oocytes harvested, fertilized, and transferred, and this increased number of oocytes transferred has been demonstrated to increase pregnancy and multiple-pregnancy rates. Multiple pregnancy with more embryos implanted would significantly reduce the abortion rate. Abortion rates decreased inversely to the number of embryos implanted. Our data strongly suggest that the efficacy of GnRH-a on IVF-ET patients was due more to the quantity increase than the quality of embryos transferred.

Key words

embryo quality embryo quantity gonadotropin releasing hormone agonist implantation rate multiple pregnancy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mar RP, Vargyas JM, Saito H, Gibbons WE, Berger T, Mishell DR Jr: Clinical applications of techniques used in human in vitro fertilization research. Am J Obstet Gynecol 1983;146:477Google Scholar
  2. 2.
    Neveu S, Hedon B, Bringer J, Chinchole MJ, Arnal F, Humeau C, Crostol P, Viala JL: Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil Steril 1987;47:639Google Scholar
  3. 3.
    Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh D: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455Google Scholar
  4. 4.
    Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, Margara RA, Franks S, Winston RML: Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinizing hormone releasing hormone. Br Med J 1988;296:1765Google Scholar
  5. 5.
    Chetkowski RJ, Rode AR, Burruel V, Nass TE: The effect of pituitary suppression and the women's age on embryo viability and uterine receptivity. Fertil Steril 1991;56:1095Google Scholar
  6. 6.
    Porter RN, Smith W, Craft JL, Abdulwahid NA, Jacobs HS: Induction of ovulation for in vitro fertilization with buserelin and gonadotropins. Lancet 1984;2:1284Google Scholar
  7. 7.
    de Ziegler D, Cedars MI, Randle D, Lu JKH, Judd H, Meldrum DR: Suppression of the ovary using a gonadotropin releasing hormone agonist prior to stimulation for the retrieval. Fertil Steril 1987;48:807Google Scholar
  8. 8.
    Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Mar RP: An alternate approach to controlled ovarian hyperstimulation in “poor responders”: Pretreatment with a gonadotropin releasing hormone analog. Fertil Steril 1988;49:90Google Scholar
  9. 9.
    Palermo R, Amodeo G, Navot D, Rosenwaks Z, Cittadini E: Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction multiple follicles. Fertil Steril 1986;49:226Google Scholar
  10. 10.
    Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:266Google Scholar
  11. 11.
    Wood C, McMaster R, Rennie G, Trounson A, Leeton J: Factors influencing pregnancy rates following in vitro fertilization and embryo transfer. Fertil Steril 1985;43:245Google Scholar
  12. 12.
    Edwards RG, Steptoe PC: Current status of in vitro fertilization and implantation of human embryos. Lancet 1983;2:1265Google Scholar
  13. 13.
    Rosenwaks Z, Muashar SJ, Acosta AA: Use of hMG and/or FSH for multiple follicle development. Clin Obstet Gynecol 1986;29:148Google Scholar
  14. 14.
    Veeck LL, Wortham JWE Jr, Witmyer J, Sandow BA, Acosta AA, Garcia JE, Jones GS, Jones HW Jr: Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril 1983;39:594Google Scholar
  15. 15.
    Jones HW Jr, Acosta AA, Wright GL Jr: A technique for the aspiration of oocytes from human ovarian follicles. Fertil Steril 1983;39:594Google Scholar
  16. 16.
    Jones HW Jr, Acosta AA, Garcia JE, Sandow BA, Veeck L: On the transfer of concepti from oocytes fertilized in vitro. Fertil Steril 1983;39:241Google Scholar
  17. 17.
    Liu H-C, Jones HW Jr, Rosenwaks Z: The efficiency of human reproduction after in vitro fertilization and embryo transfer. Fertil Steril 1988;49:649Google Scholar
  18. 18.
    Brzyski RG, Muasher SJ, Droesch K, Simonetti S, Jones GS, Rosenwaks Z: Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 1988;50:917Google Scholar
  19. 19.
    Garcia JE, Padilla SL, Bayati J, Baramki T: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: A better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302Google Scholar
  20. 20.
    Seifer DB, Lavy TG, Decherney AH: Early ovarian suppression with leuprolide acetate may be productive of IVF-ET success. 38th Annual Meeting of the Society for Gynecologic Investigation, 1991, abstr 157Google Scholar
  21. 21.
    Liu HC, Jones GS, Jones HW Jr, Rosenwaks Z: Mechanisms and factors of early pregnancy wastage in in vitro fertilization—embryo transfer patients. Fertil Steril 1988;50:95Google Scholar
  22. 22.
    Trounson AO: Factors controlling normal embryo development and implantation of human oocytes fertilized in vitro.In Fertilization of the Human Egg in Vitro, HM Beier, HR Lindner (eds). Berlin, Springer-Verlag, 1983, p 235Google Scholar
  23. 23.
    Meldrum DR, Tsao Z, Monroe SE, Braustein GD, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ: Stimulation of LH fragments with reduced bio-activity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755Google Scholar

Copyright information

© Plenum Publishing Corporation 1992

Authors and Affiliations

  • Hung-Ching Liu
    • 1
  • Ying-Ming Lai
    • 2
  • Owen Davis
    • 1
  • Alan S. Berkeley
    • 1
  • Margaret Graf
    • 1
  • Jimmy Grifo
    • 1
  • Jacques Cohen
    • 1
  • Zev Rosenwaks
    • 1
  1. 1.Center for Reproductive Medicine and Infertility, Department of Obstetrics and GynecologyCornell University Medical CollegeNew YorkUSA
  2. 2.Department of Obstetrics and GynecologyChang Gung Memorial HospitalTaipeiR.O.C.
  3. 3.Center for Reproductive Medicine and InfertilityCornell University Medical CollegeNew YorkUSA

Personalised recommendations